TABLE 1.

Patient Characteristics

	Patient
Characteristic	1	2	3	4	5	6	7	8	9	10
Sex	Female	Female	Female	Female	Male	Female	Female	Female	Female	Female
Age (y)	88	67	69	79	65	58	54	59	43	73
Primary tumor	Pancreas	Pancreas	Pancreas	Pancreas	Lung^†	Lung	Breast	Breast	Cervix	Breast
Type [stage]*	PT: DAC	PT: PAC [pT2pN2M0]	PT^†: DAC	PT: DAC [pT2N0M0]	PT^†: AC MET: AC	PT: AC [pT2bN0M0]	PT: IDC (HER2+1/ ER100%). SN without MET (0/1 LN). [M0]	PT: ILC (HER2+1/ ER100%). SN without MET (0/2 LN). [M0]	PT: SCC	PT^‡: ISPC SN with micro MET (1/2 LN). [M0]
Prior cancer treatment	None	None	CTX	None	Surgery and CTX	CTX	None	None	None	None
Concomitant cancer treatment	None	None	None	None	CTX	RDX	None	None	None	None

* Pathology TNM staging is reported in square brackets when available.
↵^†Primary tumor removed.
↵^‡Two separate tumors without connection: Tumor 1: HER2+1/ER100%; Tumor 2: HER2-/ER100%.
AC = adenocarcinoma; CTX = chemotherapy; DAC = ductal adenocarcinoma; ER = estrogen receptor; HER2 = human epidermal growth factor receptor 2; IDC = invasive ductal carcinoma; ILC = invasive lobular carcinoma; ISPC = invasive solid papillary carcinoma; LN = lymph nodes; MET = metastases; PAC = pancreaticobiliary adenocarcinoma; PT = primary tumor; RDX = radiation therapy; SCC = squamous cell carcinoma; SN = sentinel nodes.